LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis

被引:94
|
作者
Wei, Shuquan [1 ]
Wang, Kangwei [2 ]
Huang, Xiaomei [1 ]
Zhao, Zhuxiang [1 ]
Zhao, Ziwen [1 ]
机构
[1] South China Univ Technol, Affiliated Hosp 2, Dept Pulm & Crit Care Med, Guangzhou Peoples Hosp 1, 1 Panfu Rd, Guangzhou 510180, Guangdong, Peoples R China
[2] South China Univ Technol, Affiliated Hosp 2, Dept Pathol, Guangzhou Peoples Hosp 1, Guangzhou, Guangdong, Peoples R China
关键词
lncRNA MALAT1; miR-200a-3p; NSCLC; PD-L1; LONG NONCODING RNA; PROLIFERATION; PD-L1; IMMUNOTHERAPY; EXPRESSION; PATHWAY;
D O I
10.1177/2058738419859699
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study was to investigate the expression correlation between long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (lncRNA MALAT1), miR-200a-3p and programmed death-ligand 1 (PD-L1) in non-small cell lung cancer (NSCLC), and their roles in NSCLC. Real-time polymerase chain reaction (PCR) was performed to detect the expressions of MALAT1, miR-200a-3p and PD-L1 in NSCLC tissues and cells for the correlation analysis. The starBase and Targetscan databases were used to predict the binding sites between MALAT1 and miR-200a-3p, and miR-200a-3p and PD-L1, respectively. The targeting relationship between MALAT1 and miR-200a-3p, and miR-200a-3p and PD-L1 were further verified by real-time PCR and dual luciferase reporter gene assay. Cell proliferation was monitored by CCK8 and colony formation assays. The apoptosis was detected using flow cytometry. Wound healing assay and transwell assay were conducted to determine cell migration and invasion. In this study, we demonstrated that in NSCLC tissues, the expression level of MALAT1 was negatively correlated with that of miR-200a-3p, while positively correlated with PD-L1. Besides, MALAT1 promoted proliferation, mobility, migration, and invasion of NSCLC cells via sponging miR-200a-3p. PD-L1 was validated as a target of miR-200a-3p, and indirectly modulated by MALAT1. In conclusion, LncRNA MALAT1 facilitates the progression of NSCLC by modulating miR-200a-3p/PDL1 axis.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] The lncRNA MALAT1 contributes to non-small cell lung cancer development via modulating miR-124/STAT3 axis
    Li, Sen
    Mei, Zhoufang
    Hu, Hai-Bo
    Zhang, Xin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (09) : 6679 - 6688
  • [2] LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p/MDM4 axis
    Wang, Dan
    Zhang, Suhong
    Zhao, Min
    Chen, Fengling
    CANCER MEDICINE, 2020, 9 (23): : 9138 - 9149
  • [3] Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer
    Khunger, Monica
    Rakshit, Sagar
    Pasupuleti, Vinay
    Hernandez, Adrian V.
    Mazzone, Peter
    Stevenson, James
    Pennell, Nathan A.
    Velcheti, Vamsidhar
    CHEST, 2017, 152 (02) : 271 - 281
  • [4] Programmed death-ligand 1 immunohistochemistry testing for non-small cell lung cancer in practice
    Mino-Kenudson, Mari
    CANCER CYTOPATHOLOGY, 2017, 125 (07) : 521 - 528
  • [5] Temporal evolution of programmed death-ligand 1 expression in patients with non-small cell lung cancer
    Nam, Chang Hyun
    Koh, Jaemoon
    Ock, Chan-Young
    Kim, Miso
    Keam, Bhumsuk
    Kim, Tae Min
    Jeon, Yoon Kyung
    Kim, Dong-Wan
    Chung, Doo Hyun
    Heo, Dae Seog
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (04): : 975 - +
  • [6] LncRNA MALAT1 Aggravates the Progression of Non-Small Cell Lung Cancer by Stimulating the Expression of COMMD8 via Targeting miR-613
    Wang, Shouzhong
    Wang, Tao
    Liu, Darui
    Kong, Haiyan
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 10735 - 10747
  • [7] The role of lncRNA MALAT1 in bone metastasis in patients with non-small cell lung cancer
    Liu, Meijuan
    Sun, Wanli
    Liu, Yongquan
    Dong, Xiuhong
    ONCOLOGY REPORTS, 2016, 36 (03) : 1679 - 1685
  • [8] Discrepancy in Programmed Cell Death-Ligand 1 Between Primary and Metastatic Non-small Cell Lung Cancer
    Takamori, Shinkichi
    Toyokawa, Gouji
    Okamoto, Isamu
    Takada, Kazuki
    Kozuma, Yuka
    Matsubara, Taichi
    Haratake, Naoki
    Akamine, Takaki
    Katsura, Masakazu
    Mukae, Nobutaka
    Shoji, Fumihiro
    Okamoto, Tatsuro
    Oda, Yoshinao
    Iwaki, Toru
    Iihara, Koji
    Nakanishi, Yoichi
    Maehara, Yoshihiko
    ANTICANCER RESEARCH, 2017, 37 (08) : 4223 - 4228
  • [9] Update on Programmed Death-1 and Programmed Death-Ligand 1 Inhibition in the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer
    Iafolla, Marco A. J.
    Juergens, Rosalyn A.
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [10] Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer
    Cui, Yong
    Li, Guanlong
    Zhang, Xin
    Dai, Fangfang
    Zhang, Rongxiang
    ONCOLOGY LETTERS, 2018, 16 (04) : 4821 - 4828